In Vitro Diagnostics Market (Product & Service: Reagents & Kits, Instruments, and Software & Services; and Technology: Immunoassay, Clinical Chemistry, Molecular Diagnostics, Blood Glucose Monitoring, Hematology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
In Vitro Diagnostics Market – Scope of Report
TMR’s report on the global in vitro diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global in vitro diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro diagnostics market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vitro diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vitro diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro diagnostics market.
The report delves into the competitive landscape of the global in vitro diagnostics market. Key players operating in the global in vitro diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro diagnostics market profiled in this report.
Key Questions Answered in Global in vitro diagnostics Market Report
- What is the sales/revenue generated by in vitro diagnostics across all regions during the forecast period?
- What are the opportunities in the global in vitro diagnostics market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
The comprehensive report on the global in vitro diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vitro diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro diagnostics market.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global In Vitro Diagnostics Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global In Vitro Diagnostics Market Analysis and Forecasts, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. Technological Advancements
- 5.2. Regulatory Scenario
- 5.3. Price Analysis
- 5.4. Top Player Positioning
- 5.5. Covid-19 Pandemic Impact on Industry
- 6. Global In Vitro Diagnostics Market Analysis and Forecasts, By Product & Service
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Product & Service, 2017-2031
- 6.3.1. Reagents & Kits
- 6.3.2. Instruments
- 6.3.3. Software & Services
- 6.4. Market Attractiveness By Product & Service
- 7. Global In Vitro Diagnostics Market Analysis and Forecasts, By Technology
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Technology, 2017-2031
- 7.3.1. Clinical Chemistry
- 7.3.1.1. Metabolic Panel
- 7.3.1.2. Electrolyte Panel
- 7.3.1.3. Liver Panel
- 7.3.1.4. Lipid Profile
- 7.3.1.5. Renal Profile
- 7.3.1.6. Thyroid Function Panel
- 7.3.2. Immunoassay
- 7.3.2.1. ELISA
- 7.3.2.2. ELISPOT
- 7.3.2.3. Rapid Test
- 7.3.2.4. Others
- 7.3.3. Molecular Diagnostics
- 7.3.3.1. PCR
- 7.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 7.3.3.3. Microarray
- 7.3.3.4. Hybridization
- 7.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 7.3.4. Blood Glucose Monitoring
- 7.3.5. Hematology
- 7.3.6. Others (Mass Spectrometry, etc.)
- 7.4. Market Attractiveness By Technology
- 8. Global In Vitro Diagnostics Market Analysis and Forecasts, By Application
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By Application, 2017-2031
- 8.3.1. Oncology
- 8.3.2. Infectious Diseases
- 8.3.3. Metabolic Diseases
- 8.3.4. Cardiology
- 8.3.5. Nephrology
- 8.3.6. Drug Testing/pharmacogenomics
- 8.3.7. Autoimmune Diseases
- 8.3.8. Others
- 8.4. Market Attractiveness By Application
- 9. Global In Vitro Diagnostics Market Analysis and Forecasts, By End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast By End-user, 2017-2031
- 9.3.1. Diagnostic Centers
- 9.3.2. Hospital-based Laboratories
- 9.3.3. Academic & Research Institutes
- 9.3.4. Home care
- 9.3.5. Others
- 9.4. Market Attractiveness By End-user
- 10. Global In Vitro Diagnostics Market Analysis and Forecasts, By Region
- 10.1. Key Findings
- 10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness By Country/Region
- 11. North America In Vitro Diagnostics Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast By Product & Service, 2017-2031
- 11.2.1. Reagents & Kits
- 11.2.2. Instruments
- 11.2.3. Software & Services
- 11.3. Market Value Forecast By Technology, 2017-2031
- 11.3.1. Clinical Chemistry
- 11.3.1.1. Metabolic Panel
- 11.3.1.2. Electrolyte Panel
- 11.3.1.3. Liver Panel
- 11.3.1.4. Lipid Profile
- 11.3.1.5. Renal Profile
- 11.3.1.6. Thyroid Function Panel
- 11.3.2. Immunoassay
- 11.3.2.1. ELISA
- 11.3.2.2. ELISPOT
- 11.3.2.3. Rapid Test
- 11.3.2.4. Others
- 11.3.3. Molecular Diagnostics
- 11.3.3.1. PCR
- 11.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 11.3.3.3. Microarray
- 11.3.3.4. Hybridization
- 11.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 11.3.4. Blood Glucose Monitoring
- 11.3.5. Hematology
- 11.3.6. Others (Mass Spectrometry, etc.)
- 11.4. Market Value Forecast By Application, 2017-2031
- 11.4.1. Oncology
- 11.4.2. Infectious Diseases
- 11.4.3. Metabolic Diseases
- 11.4.4. Cardiology
- 11.4.5. Nephrology
- 11.4.6. Drug Testing/pharmacogenomics
- 11.4.7. Autoimmune Diseases
- 11.4.8. Others
- 11.5. Market Value Forecast By End-user, 2017-2031
- 11.5.1. Diagnostic Centers
- 11.5.2. Hospital-based Laboratories
- 11.5.3. Academic & Research Institutes
- 11.5.4. Home care
- 11.5.5. Others
- 11.6. Market Value Forecast By Country/Sub-region, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product & Service
- 11.7.2. By Technology
- 11.7.3. By Application
- 11.7.4. By End-user
- 11.7.5. By Country/Sub-region
- 12. Europe In Vitro Diagnostics Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast By Product & Service, 2017-2031
- 12.2.1. Reagents & Kits
- 12.2.2. Instruments
- 12.2.3. Software & Services
- 12.3. Market Value Forecast By Technology, 2017-2031
- 12.3.1. Clinical Chemistry
- 12.3.1.1. Metabolic Panel
- 12.3.1.2. Electrolyte Panel
- 12.3.1.3. Liver Panel
- 12.3.1.4. Lipid Profile
- 12.3.1.5. Renal Profile
- 12.3.1.6. Thyroid Function Panel
- 12.3.2. Immunoassay
- 12.3.2.1. ELISA
- 12.3.2.2. ELISPOT
- 12.3.2.3. Rapid Test
- 12.3.2.4. Others
- 12.3.3. Molecular Diagnostics
- 12.3.3.1. PCR
- 12.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 12.3.3.3. Microarray
- 12.3.3.4. Hybridization
- 12.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 12.3.4. Blood Glucose Monitoring
- 12.3.5. Hematology
- 12.3.6. Others (Mass Spectrometry, etc.)
- 12.4. Market Value Forecast By Application, 2017-2031
- 12.4.1. Oncology
- 12.4.2. Infectious Diseases
- 12.4.3. Metabolic Diseases
- 12.4.4. Cardiology
- 12.4.5. Nephrology
- 12.4.6. Drug Testing/pharmacogenomics
- 12.4.7. Autoimmune Diseases
- 12.4.8. Others
- 12.5. Market Value Forecast By End-user, 2017-2031
- 12.5.1. Diagnostic Centers
- 12.5.2. Hospital-based Laboratories
- 12.5.3. Academic & Research Institutes
- 12.5.4. Home care
- 12.5.5. Others
- 12.6. Market Value Forecast By Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. UK
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product & Service
- 12.7.2. By Technology
- 12.7.3. By Application
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
- 13. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast By Product & Service, 2017-2031
- 13.2.1. Reagents & Kits
- 13.2.2. Instruments
- 13.2.3. Software & Services
- 13.3. Market Value Forecast By Technology, 2017-2031
- 13.3.1. Clinical Chemistry
- 13.3.1.1. Metabolic Panel
- 13.3.1.2. Electrolyte Panel
- 13.3.1.3. Liver Panel
- 13.3.1.4. Lipid Profile
- 13.3.1.5. Renal Profile
- 13.3.1.6. Thyroid Function Panel
- 13.3.2. Immunoassay
- 13.3.2.1. ELISA
- 13.3.2.2. ELISPOT
- 13.3.2.3. Rapid Test
- 13.3.2.4. Others
- 13.3.3. Molecular Diagnostics
- 13.3.3.1. PCR
- 13.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 13.3.3.3. Microarray
- 13.3.3.4. Hybridization
- 13.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 13.3.4. Blood Glucose Monitoring
- 13.3.5. Hematology
- 13.3.6. Others (Mass Spectrometry, etc.)
- 13.4. Market Value Forecast By Application, 2017-2031
- 13.4.1. Oncology
- 13.4.2. Infectious Diseases
- 13.4.3. Metabolic Diseases
- 13.4.4. Cardiology
- 13.4.5. Nephrology
- 13.4.6. Drug Testing/pharmacogenomics
- 13.4.7. Autoimmune Diseases
- 13.4.8. Others
- 13.5. Market Value Forecast By End-user, 2017-2031
- 13.5.1. Diagnostic Centers
- 13.5.2. Hospital-based Laboratories
- 13.5.3. Academic & Research Institutes
- 13.5.4. Home care
- 13.5.5. Others
- 13.6. Market Value Forecast By Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product & Service
- 13.7.2. By Technology
- 13.7.3. By Application
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
- 14. Latin America In Vitro Diagnostics Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast By Product & Service, 2017-2031
- 14.2.1. Reagents & Kits
- 14.2.2. Instruments
- 14.2.3. Software & Services
- 14.3. Market Value Forecast By Technology, 2017-2031
- 14.3.1. Clinical Chemistry
- 14.3.1.1. Metabolic Panel
- 14.3.1.2. Electrolyte Panel
- 14.3.1.3. Liver Panel
- 14.3.1.4. Lipid Profile
- 14.3.1.5. Renal Profile
- 14.3.1.6. Thyroid Function Panel
- 14.3.2. Immunoassay
- 14.3.2.1. ELISA
- 14.3.2.2. ELISPOT
- 14.3.2.3. Rapid Test
- 14.3.2.4. Others
- 14.3.3. Molecular Diagnostics
- 14.3.3.1. PCR
- 14.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 14.3.3.3. Microarray
- 14.3.3.4. Hybridization
- 14.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 14.3.4. Blood Glucose Monitoring
- 14.3.5. Hematology
- 14.3.6. Others (Mass Spectrometry, etc.)
- 14.4. Market Value Forecast By Application, 2017-2031
- 14.4.1. Oncology
- 14.4.2. Infectious Diseases
- 14.4.3. Metabolic Diseases
- 14.4.4. Cardiology
- 14.4.5. Nephrology
- 14.4.6. Drug Testing/pharmacogenomics
- 14.4.7. Autoimmune Diseases
- 14.4.8. Others
- 14.5. Market Value Forecast By End-user, 2017-2031
- 14.5.1. Diagnostic Centers
- 14.5.2. Hospital-based Laboratories
- 14.5.3. Academic & Research Institutes
- 14.5.4. Home care
- 14.5.5. Others
- 14.6. Market Value Forecast By Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product & Service
- 14.7.2. By Technology
- 14.7.3. By Application
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
- 15. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
- 15.1. Introduction
- 15.1.1. Key Findings
- 15.2. Market Value Forecast By Product & Service, 2017-2031
- 15.2.1. Reagents & Kits
- 15.2.2. Instruments
- 15.2.3. Software & Services
- 15.3. Market Value Forecast By Technology, 2017-2031
- 15.3.1. Clinical Chemistry
- 15.3.1.1. Metabolic Panel
- 15.3.1.2. Electrolyte Panel
- 15.3.1.3. Liver Panel
- 15.3.1.4. Lipid Profile
- 15.3.1.5. Renal Profile
- 15.3.1.6. Thyroid Function Panel
- 15.3.2. Immunoassay
- 15.3.2.1. ELISA
- 15.3.2.2. ELISPOT
- 15.3.2.3. Rapid Test
- 15.3.2.4. Others
- 15.3.3. Molecular Diagnostics
- 15.3.3.1. PCR
- 15.3.3.2. Isothermal Nucleic Acid Amplification Technology
- 15.3.3.3. Microarray
- 15.3.3.4. Hybridization
- 15.3.3.5. DNA Sequencing & Next-Generation Sequencing
- 15.3.4. Blood Glucose Monitoring
- 15.3.5. Hematology
- 15.3.6. Others (Mass Spectrometry, etc.)
- 15.4. Market Value Forecast By Application, 2017-2031
- 15.4.1. Oncology
- 15.4.2. Infectious Diseases
- 15.4.3. Metabolic Diseases
- 15.4.4. Cardiology
- 15.4.5. Nephrology
- 15.4.6. Drug Testing/pharmacogenomics
- 15.4.7. Autoimmune Diseases
- 15.4.8. Others
- 15.5. Market Value Forecast By End-user, 2017-2031
- 15.5.1. Diagnostic Centers
- 15.5.2. Hospital-based Laboratories
- 15.5.3. Academic & Research Institutes
- 15.5.4. Home care
- 15.5.5. Others
- 15.6. Market Value Forecast By Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product & Service
- 15.7.2. By Technology
- 15.7.3. By Application
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
- 16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 16.2. Company Profiles
- 16.2.1. Danaher Corporation
- 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.1.2. Product Portfolio
- 16.2.1.3. Financial Overview
- 16.2.1.4. SWOT Analysis
- 16.2.1.5. Strategic Overview
- 16.2.2. F. Hoffmann-La Roche Ltd.
- 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.2.2. Product Portfolio
- 16.2.2.3. Financial Overview
- 16.2.2.4. SWOT Analysis
- 16.2.2.5. Strategic Overview
- 16.2.3. Thermo Fisher Scientific Inc.
- 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.3.2. Product Portfolio
- 16.2.3.3. Financial Overview
- 16.2.3.4. SWOT Analysis
- 16.2.3.5. Strategic Overview
- 16.2.4. Becton, Dickinson, and Company
- 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.4.2. Product Portfolio
- 16.2.4.3. Financial Overview
- 16.2.4.4. SWOT Analysis
- 16.2.4.5. Strategic Overview
- 16.2.5. QIAGEN N.V.
- 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.5.2. Product Portfolio
- 16.2.5.3. Financial Overview
- 16.2.5.4. SWOT Analysis
- 16.2.5.5. Strategic Overview
- 16.2.6. bioMérieux SA
- 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.6.2. Product Portfolio
- 16.2.6.3. Financial Overview
- 16.2.6.4. SWOT Analysis
- 16.2.6.5. Strategic Overview
- 16.2.7. Siemens Healthcare GmbH
- 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.7.2. Product Portfolio
- 16.2.7.3. Financial Overview
- 16.2.7.4. SWOT Analysis
- 16.2.7.5. Strategic Overview
- 16.2.8. Abbott Laboratories
- 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.8.2. Product Portfolio
- 16.2.8.3. Financial Overview
- 16.2.8.4. SWOT Analysis
- 16.2.8.5. Strategic Overview
- 16.2.9. Agilent Technologies, Inc.
- 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.9.2. Product Portfolio
- 16.2.9.3. Financial Overview
- 16.2.9.4. SWOT Analysis
- 16.2.9.5. Strategic Overview
- 16.2.10. Bio-Rad Laboratories, Inc.
- 16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.10.2. Product Portfolio
- 16.2.10.3. Financial Overview
- 16.2.10.4. SWOT Analysis
- 16.2.10.5. Strategic Overview
- 16.2.11. Chembio Diagnostics, Inc.
- 16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.11.2. Product Portfolio
- 16.2.11.3. Financial Overview
- 16.2.11.4. SWOT Analysis
- 16.2.11.5. Strategic Overview
- 16.2.12. Sysmex Corporation
- 16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.12.2. Product Portfolio
- 16.2.12.3. Financial Overview
- 16.2.12.4. SWOT Analysis
- 16.2.12.5. Strategic Overview
- 16.2.13. QuidelOrtho Corporation.
- 16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.13.2. Product Portfolio
- 16.2.13.3. Financial Overview
- 16.2.13.4. SWOT Analysis
- 16.2.13.5. Strategic Overview
- 16.2.14. Illumina, Inc.
- 16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.2.14.2. Product Portfolio
- 16.2.14.3. Financial Overview
- 16.2.14.4. SWOT Analysis
- 16.2.14.5. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook